Embecta (EMBC) Change in Accured Expenses (2020 - 2026)
Embecta's (EMBC) quarterly Change in Accured Expenses came in at $8.8 million in Q1 2026, up 144.67% year-on-year from $3.6 million in Q1 2025, and up 136.97% quarter-over-quarter from -$23.8 million in Q4 2025.
Embecta (EMBC) Change in Accured Expenses (2020 - 2026) Analysis & Trends
Embecta has disclosed Change in Accured Expenses across 7 years of filings, most recently posting $8.8 million for Q1 2026.
- Change in Accured Expenses for Q1 2026 came in at $8.8 million, up 144.67% year-over-year; the trailing twelve-month figure through Mar 2026 was -$23.4 million (down 2500.0% YoY), and the FY2025 annual result was -$68.9 million, down 214.83% from the prior year.
- Change in Accured Expenses came in at $8.8 million for Q1 2026 at Embecta, up from -$23.8 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $88.4 million in Q2 2022 to a low of -$45.4 million in Q3 2023.
- The 5-year median for Change in Accured Expenses is $3.3 million (2025), against an average of $3.7 million.
- Across the five-year window, Change in Accured Expenses slumped 1294.74% in 2023 and surged 5266.67% in 2024, its largest moves.
- Embecta's Change in Accured Expenses stood at $19.4 million in 2022, then plunged by 180.93% to -$15.7 million in 2023, then tumbled by 159.87% to -$40.8 million in 2024, then soared by 41.67% to -$23.8 million in 2025, then surged by 136.97% to $8.8 million in 2026.
- The last three Change in Accured Expenses figures came in at $8.8 million (Q1 2026), -$23.8 million (Q4 2025), and -$11.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -284.70 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | - |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -32.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 103.88 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | - |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -151.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | - |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 5.38 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 203.00 Mn |
| 10 | Embecta | 183.23 Mn | -10.17 Mn | 127.80 Mn | 8.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.80 Mn |
| Mar 31, 2026 | 8.80 Mn |
| Dec 31, 2025 | -23.80 Mn |
| Dec 31, 2025 | -23.80 Mn |
| Sep 30, 2025 | -11.70 Mn |
| Sep 30, 2025 | -11.70 Mn |
| Jun 30, 2025 | 3.30 Mn |
| Jun 30, 2025 | 3.30 Mn |
| Mar 31, 2025 | -19.70 Mn |
| Mar 31, 2025 | -19.70 Mn |
| Dec 31, 2024 | -40.80 Mn |
| Dec 31, 2024 | -40.80 Mn |
| Sep 30, 2024 | 25.50 Mn |
| Sep 30, 2024 | 25.50 Mn |
| Jun 30, 2024 | 34.10 Mn |
| Jun 30, 2024 | 34.10 Mn |
| Mar 31, 2024 | 16.10 Mn |
| Mar 31, 2024 | 16.10 Mn |
| Dec 31, 2023 | -15.70 Mn |
| Dec 31, 2023 | -15.70 Mn |